HSCs from adult mice show unaltered differentiation, proliferation, and repopulating capacity. Therefore, in contrast to its role in embryonic hematopoiesis, Smad5 is dispensable for hematopoiesis in the adult mouse.
Introduction TGF-β superfamily members, including the TGF-βs, Activins and BMPs, regulate a wide variety of biological functions such as cell proliferation, differentiation, migration and apoptosis in a context dependent manner. 1 Signaling by these growth factors is initiated when binding of the ligand induces the assembly of a heteromeric complex of type I and type II serine/threonine kinase receptors. The type I receptors, also known as activin receptor-like kinases (ALKs), are recruited by the type II receptors and activate specific receptor-regulated Smads (R-Smads: Smad1-3, 5, and 8) by phosphorylation. 2, 3 Activated R-Smads then form complexes with the commonpartner Smad4 and translocate into the nucleus, where they participate in transcriptional regulation of target genes. 2, 3 Conversely, inhibitory Smads (I-Smad:
Smad6 and 7) negatively regulate TGF-β signaling by competing with the R-Smads for receptor or Smad4 interaction, and by marking the receptors for degradation by recruiting the E3-ubiquitin ligase. 2, 4 Generally, Smad2 and 3 act downstream of the TGF-β and activin receptors, while Smad1, 5, and 8 primarily mediate BMP signals.
In endothelial cells, however, TGF-β signals both via ALK5 and ALK1, inducing phosphorylation of Smad2/3 and Smad1/5 respectively, playing an important role in balancing processes of angiogenesis. 5, 6 The relevance of TGF-β signaling mediated by Smad1/5 in hematopoiesis is unclear, although Smad5 has been implicated in transducing TGF-β inhibitory signals in hematopoietic progenitors derived from human BM and murine yolk sac. 7, 8 Several members of the TGF-β superfamily, and the Smads mediating their signals, are involved in the regulation of fate decisions of hematopoietic progenitors and stem cells. 9, 10 Homozygous disruption of the Smad5 gene is embryonic lethal at E9.5 to 
Materials and methods Mice
Mice with a "floxed" Smad5 allele (loxP flanked exon 2) for Cre-mediated conditional knockout have been previously described. 17 
Flow cytometry
Rat antibodies against murine Mac1, Gr1, B220, CD3, Sca-1, c-kit, CD34, CD45.1 supplemented with 50 ng/ml SCF, 50 ng/ml human thrombopoietin (TPO; Peprotech Inc.), and 5 U/ml human erythropoietin (Epo; Janssen-Cilag AB, Sollentuna, Sweden). CFU-GMs were scored on day 7 and BFU-Es on day 9-10. CFU-GMs were also plated with and without human TGF-β1 at indicated doses (Peprotech, Inc.). 
Single-cell cultures

Smad5 deficient hematopoietic progenitors retain normal proliferation and differentiation capacity in vitro
Smad5 has been suggested to negatively regulate the proliferation of early multipotent hematopoietic progenitors derived from yolk sac and embryonic bodies in vitro. 
Smad5 deficient progenitors show normal sensitivity to TGF-β1 inhibition
Recent findings have shown that BMP4 stimulates proliferation and colony formation of primitive human cord blood progenitors in vitro. 15 While murine BM cells propagate a BMP4 signal through phosphorylation of Smad1/Smad5, BMP4 does not have analogous effects on murine progenitor proliferation or colony formation. 20 However, Smad5 has also been reported to transduce inhibitory signals from TGF-β1 in hematopoietic progenitors from both human BM, 7 and murine embryonic bodies. in their response to TGF-β1 inhibition at any of the concentrations used ( Figure 2D ).
For personal use only. on October 3, 2017. by guest www.bloodjournal.org From Additionally, we plated whole BM for CFU-GM formation with and without three different concentrations of TGF-β1 (0.1, 1, and 10 ng/ml). Again, the results showed no difference in either the number of colonies formed ( Figure 2B , data not shown) or in their sensitivity to TGF-β1 ( Figure 2E ). Taken together this suggests that Smad5 is not required for TGF-β1 inhibition of hematopoietic progenitors from adult mice in vitro. were not different from wt control animals, suggesting no effects of Smad5 deletion on PB homeostasis (Table 1) . Furthermore, FACS analysis of PB, BM and spleen showed unperturbed ratios of myeloid cells (Mac-1, Gr-1), B-cells (B220), and T-cells (CD3) (Figure 3A-C) . Additionally, analysis of BM showed normal numbers of both total cells and the primitive LSK CD34 -cell population that is highly enriched for HSCs (Table 1) . Taken together, these results suggest that Smad5 is dispensable for the maintenance of the hematopoietic system under steady state conditions.
Steady state hematopoiesis is unperturbed in induced
Normal competitive repopulation ability and lineage distribution in vivo after BM transplantation of Smad5 deficient cells.
Since Smad5 has been implied to negatively regulate the proliferation and selfrenewal of multipotent progenitors during murine embryonic hematopoiesis, 8 we reconstitution of the primary recipients ( Figure 4B ). In agreement with the unaltered repopulative capacity of Smad5 -/-BM, the number of primitive LSK cells within the donor derived BM population remained unchanged (Table 2) . Furthermore, the contribution of donor derived cells to the myeloid and lymphoid compartments was Additionally, we performed a limiting dilution transplantation using four different doses, ranging from 5000 to 50000 cells, of unfractionated BM from induced 
Discussion
As the conventional Smad5 knockout mouse is embryonic lethal, all previous knowledge about the role of Smad5 in murine hematopoiesis has been inferred from studies on cells of embryonic origin. Smad5 negatively regulates the proliferation of early multipotent hematopoietic progenitors derived from yolk sac and embryonic bodies in vitro. 8 In the same study Smad5 deficient embryonic bodies gave rise to decreased numbers of erythroid progenitors, while myeloid progenitors were unaffected. 8 Another murine study, however, showed a two fold increase in the capacity of Smad5 -/-yolk sac cells to form CFU-GMs, while their capacity to form erythroid colonies was unchanged. 12 Although the effect of Smad5 deficiency on differentiation in embryonic hematopoiesis is not conclusive, Smad5 seems to play a role in embryonic hematopoietic development. In contrast, our study clearly shows Our results suggest that the developmental context is an important factor in defining the role for Smad5 in hematopoiesis. In humans, a role for BMP signaling in hematopoiesis has also mainly been reported early in ontogeny. Apart from being essential for regulation of early hematopoietic development, 13 BMP4 has been shown to promote hematopoietic differentiation of human embryonic stem cells, 14 and to stimulate proliferation and colony formation of human primitive progenitors purified from CB in vitro. 15 However, BMP4 does not have a stimulatory effect on either proliferation or colony formation of hematopoietic progenitors from murine BM. 20 This discrepancy in response to BMP4 may depend on biological differences between mouse and human, but also on ontogenic differences. In fact, Bhatia et al.
demonstrated significant expression of ALK-3 and ALK-6 in HSCs derived from human CB, while the expression level of these BMP type I receptors in BM HSCs was very low to undetectable. The absence of these receptors has also been documented in mouse BM. 20 Together this implies that cells of early ontogeny may reflect a unique population of HSCs with a distinct response to growth factors. For
Figure 4
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